Prologue Journal

The FDA’s See-No-Data Approach

• prologu5
• 09/26/202309/26/2023

Wall Street Journal

A study showed promise in treating a rare disease. The agency wouldn’t even look at the results.

https://www.wsj.com/articles/fda-food-and-drug-admin-arg1-d-pegzilarginase-aeglea-biotherapeutics-arginine-deficiency-healthcare-c9e8c21f